📰 Dose Management News
Page 2 - Dose Management News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Dose Management. Real-time updates on events, politics, business and more.
September 25, 2023
/PRNewswire/ -- BioArctic ABs (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today that "LEQEMBI® Intravenous Infusion" (200 mg, 500mg, lecanemab)...
September 25, 2023
STOCKHOLM, Sept. 25, 2023 /PRNewswire/ -- BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai...
September 25, 2023
STOCKHOLM, Sept. 25, 2023 /PRNewswire/ -- BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai...
September 25, 2023
STOCKHOLM, Sept. 25, 2023 /PRNewswire/ -- BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai...
July 20, 2023
STOCKHOLM, July 20, 2023 /PRNewswire/ -- BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai...
July 20, 2023
Further Phase 3 analysis shows benefits of lecanemab on both amyloid-beta and tau, two underlying pathological hallmarks of Alzheimer’s disease ...
July 20, 2023
/PRNewswire/ -- BioArctic ABs (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today that the results of a detailed analysis of the Phase 3 Clarity...
July 11, 2023
/PRNewswire/ -- Alzheimers disease (AD) researchers increasingly believe that treating at the earliest possible stage may be key to helping combat the disease....
July 11, 2023
SAN DIEGO, July 11, 2023 /PRNewswire/ -- Alzheimers disease (AD) researchers increasingly believe that treating at the earliest possible stage ma...
July 7, 2023
STOCKHOLM, July 7, 2023 /PRNewswire/ -- BioArctic AB's (publ) (NASDAQ Stockholm: BIOA B) partner Eisai...